Tokotant Corporation – Trademark Portfolio

Entity Type: 03

Tokotant Corporation holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AYAKI. The owner is based in Kyoto-shi, Kyoto.

300-1 Hanjo-cho, Shimogyo-ku

Kyoto-shi, Kyoto 600-8433 , JP

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AYAKI
AYAKI
Registered 2022

Trademark Classifications

Tokotant Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Tokotant Corporation have?

Tokotant Corporation has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Tokotant Corporation file in?

Tokotant Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Tokotant Corporation's most well-known trademarks?

Tokotant Corporation's registered trademark portfolio includes well-known marks such as AYAKI. These are among 1 currently registered trademark in the portfolio.

What is Tokotant Corporation's trademark registration success rate?

Tokotant Corporation has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.